These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22321253)

  • 41. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
    Bellacosa A; Almadori G; Cavallo S; Cadoni G; Galli J; Ferrandina G; Scambia G; Neri G
    Clin Cancer Res; 1996 Jan; 2(1):175-80. PubMed ID: 9816104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
    Lee SJ; Lee SY; Jeon HS; Park SH; Jang JS; Lee GY; Son JW; Kim CH; Lee WK; Kam S; Park RW; Park TI; Kang YM; Kim IS; Jung TH; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):571-5. PubMed ID: 15767331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
    Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor gene polymorphisms in North Indian patients with end stage renal disease.
    Prakash S; Prasad N; Sharma RK; Faridi RM; Agrawal S
    Cytokine; 2012 May; 58(2):261-6. PubMed ID: 22370607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
    Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
    Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
    Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
    Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma.
    Gomes CC; Drummond SN; Guimarães AL; Andrade CI; Mesquita RA; Gomez RS
    J Oral Pathol Med; 2008 Mar; 37(3):151-6. PubMed ID: 18251939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Val allele of HER-2 codon 655 predicts the progression of oral squamous cell carcinoma.
    Wu CH; Tu HF; Gong NR; Chen YW; Liu CJ; Kao SY
    Oral Oncol; 2009 Jul; 45(7):579-83. PubMed ID: 18849186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Association Between VEGF +936C/T and -634G/C Polymorphisms and Breast Cancer Susceptibility, Tumor Growth, and Metastases: Evidence From 20,728 Subjects.
    Ma J; Hu W; Zhang P; Sun Y; Wang N; Teng X; Qiao Q
    Cancer Invest; 2015; 33(7):312-7. PubMed ID: 26067906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.
    Cortessis VK; Siegmund K; Xue S; Ross RK; Yu MC
    Carcinogenesis; 2003 Oct; 24(10):1645-50. PubMed ID: 12896908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
    Stocker G; Ott K; Henningsen N; Becker K; Hapfelmeier A; Lordick F; Hois S; Plaschke S; Höfler H; Keller G
    Eur J Cancer; 2009 Dec; 45(18):3326-35. PubMed ID: 19822419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women.
    Jeon YT; Kim JW; Song JH; Park NH; Song YS; Kang SB; Lee HP
    Cancer Lett; 2005 Jun; 223(2):259-63. PubMed ID: 15896460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.
    Steffensen KD; Waldstrøm M; Brandslund I; Jakobsen A
    Gynecol Oncol; 2010 Apr; 117(1):109-16. PubMed ID: 20056267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea.
    Bae SJ; Kim JW; Kang H; Hwang SG; Oh D; Kim NK
    Anticancer Res; 2008; 28(2B):1271-6. PubMed ID: 18505065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An update on the implications of cyclin D1 in oral carcinogenesis.
    Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
    Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival to oral cancer. A study of clinical risk markers with independent prognostic value.
    Varela-Centelles PI; Seoane J; Vázquez Fernández E; De La Cruz A; García Asenjo JA
    Bull Group Int Rech Sci Stomatol Odontol; 2002; 44(2):46-51. PubMed ID: 12577522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single nucleotide polymorphisms of the vascular endothelial growth factor gene associated with incidence of oral squamous cell carcinoma.
    Kämmerer PW; Toyoshima T; Eletr S; Kämmerer P; Kuhr K; Al-Nawas B; Brieger J
    J Oral Pathol Med; 2010 Nov; 39(10):786-92. PubMed ID: 20618614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer.
    Ku KT; Wan L; Peng HC; Tsai MH; Tsai CH; Tsai FJ
    Oral Oncol; 2005 May; 41(5):497-502. PubMed ID: 15878754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.